Track the CLEO DIAGNOSTICS LTD stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on AU AU, under the oversight of ASX. Market capitalisation: €67.2m. The latest transaction was filed on 7 July 2026 (Purchase). Among the most active insiders: Unknown. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
CLEO DIAGNOSTICS LTD is a company listed on the XASX, specializing in the development of medical diagnostic solutions. It focuses on innovation in diagnostic testing to enhance healthcare.